M
Maria Gabriella Raimondo
Researcher at University of Milan
Publications - 25
Citations - 715
Maria Gabriella Raimondo is an academic researcher from University of Milan. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 12, co-authored 21 publications receiving 498 citations. Previous affiliations of Maria Gabriella Raimondo include University of Erlangen-Nuremberg.
Papers
More filters
Journal ArticleDOI
Sex and Management of Rheumatoid Arthritis
Ennio Giulio Favalli,Martina Biggioggero,Chiara Crotti,Andrea Becciolini,Maria Gabriella Raimondo,Pier Luigi Meroni +5 more
TL;DR: A better comprehension of possible factors influencing sexual dimorphism in RA susceptibility, pattern of presentation, disease activity, and outcome could contribute to a tailored approach to limit the morbidity of the disease.
Journal ArticleDOI
Profile of sarilumab and its potential in the treatment of rheumatoid arthritis.
Maria Gabriella Raimondo,Martina Biggioggero,Chiara Crotti,Andrea Becciolini,Ennio Giulio Favalli +4 more
TL;DR: This review summarizes both the biological role of IL-6 in RA and the clinical data available on sarilumab as an alternative therapeutic option in RA patients, showing a clear head-to-head superiority over adalimumab in MTX-intolerant subjects.
Journal ArticleDOI
The X chromosome and the sex ratio of autoimmunity.
TL;DR: The present article will critically discuss the main hypotheses (loss of mosaicism, reactivation, and haploinsufficiency) that have been proposed based on findings in female patients with specific AID along with two additional mechanisms (X-chromosome vulnerability and X-linked polyamine genes) that has been observed in AID models.
Journal ArticleDOI
Cutaneous Manifestations of ANCA-Associated Small Vessels Vasculitis.
Angelo V. Marzano,Maria Gabriella Raimondo,Emilio Berti,Pier Luigi Meroni,Francesca Ingegnoli +4 more
TL;DR: This review focuses on the cutaneous manifestations that can develop in the context of ANCA-associated vasculitis, detailing the clinical features, the histopathological aspects as well as the direct immunofluorescence studies for each of the three conditions.
Journal ArticleDOI
The management of first-line biologic therapy failures in rheumatoid arthritis: Current practice and future perspectives.
Ennio Giulio Favalli,Maria Gabriella Raimondo,Andrea Becciolini,Chiara Crotti,Martina Biggioggero,Roberto Caporali +5 more
TL;DR: All the potential therapeutic options for the treatment of first-line bDMARD failures are analyzed in order to provide a comprehensive overview of available strategies to be applied in clinical practice.